Medical Device News Magazine

UCSD John B. West Distinguished Lecture Series, Sponsored by MediPines | Featuring Nobel Laureate Dr. Gregg L Semenza

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

MediPines, the pioneering market leader in non-invasive pulmonary gas exchange technology, and maker of AGM100, will sponsor this year’s annual UCSD John B. West Distinguished Lecture event featuring Nobel Laureate Gregg L. Semenza, MD, PhD.

The lecture, titled “Hypoxia-Inducible Factors in Physiology and Medicine,” will take place on August 7, 2023 at noon pacific time via livestream from UCSD.

“We’re honored to be hosting the esteemed Dr. Semenza, a pioneer and expert on studying how cells adapt to changing oxygen levels and molecular mechanisms of oxygen homeostasis,” said Dr. Jason Yuan, Professor and Director, Section of Physiology of the Division of Pulmonary, Critical Care and Sleep Medicine at UCSD. Dr. Yuan is a co-author of Ganong’s Review of Medical Physiology.

“We’re delighted to have Dr. Gregg L Semenza speak on this very important topic in medicine. He is an outstanding example of a physician scientist whose work has set the bedrock for numerous clinical innovations,” said MediPines CEO, Steve Lee, who co-invented non-invasive pulmonary gas exchange monitoring technology, AGM100, with Dr. West.

Dr. Semenza, the C. Michael Armstrong Professor of Genetic Medicine at Johns Hopkins University, was awarded the Nobel Prize in Physiology or Medicine, with William G. Kaelin, Jr. and Peter J. Ratcliffe in 2019 for his groundbreaking discovery of the hypoxia-inducible factor (HIF) protein. His research on molecular mechanisms of oxygen homeostasis and oxygen sensing has generated more than 500 research articles.

After introductory notes by Zea Borok, MD (Chair of Medicine, UCSD); Jess Mandel, MD, (Chief of Pulmonary, Critical Care and Sleep Medicine, UCSD); John B. West, MD, PhD, DSc (Emeritus Professor of Medicine and Physiology at UCSD); and Steve Lee (CEO of MediPines), Dr. Semenza will deliver his lecture. After the presentation and a brief Q&A session, Dr. West will present a plaque and honorarium to Dr. Semenza.

As part of the program, there will also be a clinical presentation from a UCSD physician-scientist after the lecture.

Registration for the event can be accessed here: https://medipines.com/jbwlecture2023

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”